Tian An Medicare 과거 수익 실적

과거 기준 확인 3/6

Tian An Medicare은 연평균 5.7%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 수입이 증가했으며, 연간 7.2%였습니다. 매출은 연평균 6.7%의 비율로 증가했습니다. Tian An Medicare의 자기자본이익률은 2.4%이고 순이익률은 1.9%입니다.

주요 정보

5.7%

수익 성장률

5.1%

EPS 성장률

Healthcare 산업 성장	15.7%
매출 성장률	6.7%
자기자본 수익률	2.4%
순이익	1.9%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

Tian An Medicare 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

DB:SMI 수익, 비용 및 수입 (HKD Millions )
날짜	수익	수익	G+A 비용
30 Jun 24	1,629	32	229
31 Mar 24	1,599	21	233
31 Dec 23	1,569	11	237
30 Sep 23	1,516	-32	246
30 Jun 23	1,463	-78	257
31 Mar 23	1,450	-101	258
31 Dec 22	1,438	-124	259
30 Sep 22	1,464	-115	245
30 Jun 22	1,491	-107	231
31 Mar 22	1,477	-122	228
31 Dec 21	1,463	-137	225
30 Sep 21	1,447	-127	232
30 Jun 21	1,430	-116	238
31 Mar 21	1,312	-114	233
31 Dec 20	1,194	-112	228
30 Jun 20	1,099	-81	238
31 Mar 20	1,163	-40	240
31 Dec 19	1,228	1	243
30 Jun 19	1,196	35	246
31 Mar 19	1,168	-8	245
31 Dec 18	1,139	-52	243
30 Sep 18	1,120	-94	246
30 Jun 18	1,101	-137	248
31 Mar 18	1,115	-198	249
31 Dec 17	1,130	-258	249
30 Sep 17	1,207	-165	245
30 Jun 17	1,284	-72	241
31 Mar 17	1,791	-143	251
31 Dec 16	2,297	-214	261
30 Sep 16	2,349	-498	243
30 Jun 16	2,400	-783	225
31 Mar 16	1,787	-375	195
31 Dec 15	1,175	33	165
30 Sep 15	945	131	153
30 Jun 15	715	228	141
31 Mar 15	859	233	197
31 Dec 14	1,003	237	253
30 Sep 14	1,050	582	232
30 Jun 14	1,096	928	211
31 Dec 13	219	-363	-4

양질의 수익: SMI 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: SMI 는) 과거에 수익을 냈습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: SMI 지난 5년 동안 수익을 창출하여 매년 5.7% 수익을 올렸습니다.

성장 가속화: SMI 지난해 흑자를 기록해 5년 평균과 비교하기 어려운 수익 성장률을 보이고 있습니다.

수익 대 산업: SMI 작년에 수익을 올렸기 때문에 지난 해 수익 성장을 Healthcare 업계( 40.5% )와 비교하기가 어렵습니다.

Tian An Medicare 과거 수익 실적

과거 기준 확인 3/6

주요 정보

최근 과거 실적 업데이트

First half 2024 earnings released: EPS: HK$0.02 (vs HK$0.002 in 1H 2023)

First half 2024 earnings released: EPS: HK$0.02 (vs HK$0.002 loss in 1H 2023)

Tian An Medicare Limited to Report Q4, 2024 Results on Aug 02, 2024

Full year 2023 earnings released: EPS: HK$0.012 (vs HK$0.17 loss in FY 2022)

Full year 2023 earnings released: EPS: HK$0.012 (vs HK$0.17 loss in FY 2022)

China Medical & HealthCare Group Limited to Report Fiscal Year 2023 Final Results on Mar 15, 2024

Recent updates

New major risk - Share price stability

New minor risk - Market cap size

First half 2024 earnings released: EPS: HK$0.02 (vs HK$0.002 in 1H 2023)

First half 2024 earnings released: EPS: HK$0.02 (vs HK$0.002 loss in 1H 2023)

Tian An Medicare Limited to Report Q4, 2024 Results on Aug 02, 2024

Upcoming dividend of HK$0.01 per share

Full year 2023 earnings released: EPS: HK$0.012 (vs HK$0.17 loss in FY 2022)

China Medical & Healthcare Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 02 August 2024

Full year 2023 earnings released: EPS: HK$0.012 (vs HK$0.17 loss in FY 2022)

China Medical & HealthCare Group Limited, Annual General Meeting, May 20, 2024

China Medical & HealthCare Group Limited to Report Fiscal Year 2023 Final Results on Mar 15, 2024

New minor risk - Market cap size

China Medical & Healthcare Group Limited Provides Earnings Guidance for Eleven Months Ended 30 November 2023

China Medical & Healthcare Group Limited Announces Company Secretary and Authorised Representative Changes

China Medical & HealthCare Group Limited Announces Change in the Composition of the Board of Directors and Change of Members of the Board Committees

Tian An China Investments Company Limited (SEHK:28) completed the acquisition of 18.13% stake in China Medical & HealthCare Group Limited (SEHK:383) from its shareholders for approximately HKD 180 million.

China Medical & Healthcare Group Limited Announces Resignation of Chong Sok Un as Executive Director and Deputy Chairman and Change in Composition of the Board Committees

First half 2023 earnings released: HK$0.002 loss per share (vs HK$0.061 loss in 1H 2022)

China Medical & HealthCare Group Limited to Report Second Half, 2023 Results on Aug 18, 2023

China Medical & HealthCare Group Limited Provides Group Earnings Guidance for the Five Months Ended 31 May 2023

Less than half of directors are independent

Full year 2022 earnings released: HK$0.17 loss per share (vs HK$0.19 loss in FY 2021)

Less than half of directors are independent

China Medical & Healthcare Group Limited Provides Consolidated Earnings Guidance for the Eleven Months Ended 30 November 2022

Less than half of directors are independent

China Medical & Healthcare Group Limited Announces Executive Changes

First half 2022 earnings released: HK$0.003 loss per share (vs HK$0.005 loss in 1H 2021)

China Medical & HealthCare Group Limited Provides Unaudited Consolidated for the Five Months Ended 31 May 2022

Less than half of directors are independent

Full year 2021 earnings released: HK$0.009 loss per share (vs HK$0.008 loss in FY 2020)

China Medical & HealthCare Group Limited, Annual General Meeting, Jun 01, 2022

Now 31% undervalued after recent price drop

Now 44% undervalued after recent price drop

First half 2021 earnings released: HK$0.005 loss per share (vs HK$0.005 loss in 1H 2020)

First half 2021 earnings released: HK$0.005 loss per share (vs HK$0.005 loss in 1H 2020)

China Medical & HealthCare Group Limited Provides Unaudited Consolidated Earnings Guidance for the Four Months Ended April 30, 2021

Executive Director has left the company

Non-Executive Director has left the company

Chairman Liye Zhou has left the company

China Medical & HealthCare Group Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

China Medical & Healthcare Group Limited Appoints Lai Hin Wing Henry Stephen as Non-Executive Director, Effective November 11, 2020

First half earnings released

China Medical & HealthCare Group Limited to Report 18 Months Period Ending Dec 31, 2019 Results on Mar 30, 2020

China Medical & HealthCare Group Limited to Report Second Half, 2020 Results on Aug 27, 2020

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기